Receive The Newest Study Notifications

Preliminary Data from NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax’s M-001 Universal Influenza Vaccine Candidate Validates Results of Previous Clinical Trials

by Lance Smith | Feb 6, 2020 | Study Scavenger Clinical Trial Recruitment Platform

JERUSALEM, Feb. 5, 2020 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) announced today that preliminary data from the Phase 2 clinical trial of BiondVax’s M-001 universal influenza vaccine candidate have been published. The trial was supported...

Minerva Neurosciences Announces Completion of Patient Enrollment in Phase 3 Trial of Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

by Lance Smith | Feb 6, 2020 | Study Scavenger Clinical Trial Recruitment Platform

WALTHAM, Mass., Feb. 05, 2020 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies addressing high unmet medical needs in the treatment of central nervous system (CNS)...

BioXcel Therapeutics Announces FDA Clearance of IND Application for BXCL501 for the Treatment of Opioid Withdrawal Symptoms / Company is preparing to initiate Phase 1b/2 RELEASE trial

by Lance Smith | Feb 6, 2020 | Study Scavenger Clinical Trial Recruitment Platform

NEW HAVEN, Conn., Feb. 05, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to identify and advance the next wave of medicines in...

STAAR Surgical Announces the EVO Implantable Lens US Clinical Trial is Underway with 1st Patient Implanted at Price Vision Group in Indianapolis on January 30th

by Lance Smith | Feb 6, 2020 | Study Scavenger Clinical Trial Recruitment Platform

LAKE FOREST, Calif. & INDIANAPOLIS–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the first patient was implanted...

Moleculin Announces Successful Completion of US Phase 1 AML Trial of Annamycin

by Lance Smith | Feb 3, 2020 | Study Scavenger Clinical Trial Recruitment Platform

HOUSTON, Feb. 3, 2020 /PRNewswire/ –Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today...

Lantheus Announces Topline Results for BENEFIT 1 LVEF Clinical Trial

by Lance Smith | Feb 3, 2020 | Study Scavenger Clinical Trial Recruitment Platform

NORTH BILLERICA, Mass.–(Business Wire)–Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus” or the “Company”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of innovative diagnostic...